Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner
Norman L
NL
keltner@uab.edu
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D015984:Causality; D015897:Comorbidity; D006801:Humans; D008019:Life Style; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control; D024802:Nurse's Role; D010353:Patient Education as Topic; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D015430:Weight Gain / Q000187:drug effects
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents